Cosentyx subcutaneous injection 150 mg pen, manufactured by Novartis Pharma, contains secukinumab (genetical recombination). This subcutaneous injection is used to treat conditions such as moderate to severe plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis. This product is a 150 mg pen with YJ code 3999439G2028 and is listed as 1mg 1mL per tube.
Cosentyx subcutaneous injection 150 mg pen
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →